The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
SBC: Op-T-Mune, Inc Topic: NIAID
TypeDiabetesT Daffects an ever growing populationWhile this disease typically has been associated with juvenilesthe disease in adult populations is rapidly increasingThe defining clinical component is insulin losswhich occurs because of sustained inflammation in the isletsAt present there is no means to prevent or reverse insulin lossA major inflammatory pathway in T D that contributes to insulin ...STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
SBC: Promiliad Biopharma Incorporated Topic: NIAID
SPECIFIC AIMSAntibiotic resistance among common bacterial pathogens is a serious public health problem as it compromises our ability to treat infectious diseaseThe resistance problem is compounded by the relative lack of discovery of new antibioticsespecially those with novel mechanisms of actionNew antibiotics are critically needed as resistance to recently developed antibiotics is growingThe goa ...STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
SBC: Cetya Therapeutics, Inc. Topic: NHLBI
PROJECT SUMMARY Thehemoglobinopathies are prevalent genetic blood diseases with few treatment optionsIt is estimate thatof the worldandapos s population carries an abnormal hemoglobin gene withinfants born annually with a severe life threatening hemoglobinopathyDrug mediated induction of normalbut developmentally silencedfetal hemoglobinHbFexpression reduces anemia and ameliorates clinical severit ...STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health